DCTD National Cancer Institute / National Cancer Institute / / /
IndustryTerm
quality auditing / proposed combination protocols / cancer cooperative / transportation / through site visit auditing / pharmaceutical industry / Cancer Therapy / cancer therapies / Cancer Treatment / pharmaceutical / final approved protocol / manufacturing processes / clinical protocols / investigational and marketing applications / clinical research protocol / care of the disease / cooperative groups / treatment of cancer / cancer care / analogous product / patent law / pharmaceutical data / /
MedicalCondition
particular disease / cancer / disease / specific tumor / diseases / injuries / /
MedicalTreatment
clinical protocol / clinical research protocol / anti-cancer therapies / Cancer Therapy / clinical protocols / investigational therapies / /
Organization
National Cancer Institute / Division of Cancer Treatment and Diagnosis / National Institute of Health / DHHS / Food and Drug Administration / U.S. Public Health Service / CTEP Protocol Review Committee / HHS office of Human Research Protection / U.S. Government / U.S.C. Chapter / Federal Government / Other Party / FDA / DCTD National Cancer Institute / Department of Health and Human Services / C. Either Party / Steering Committee / Clinical Trials Monitoring Service / Protocol Review Committee / /
Person
Robert Wittes / Collaborator / Sherry S. Ansher / Alfred Fallavollita / Sherry Ansher / / /
Position
Investigator / Coordinator / Research & Development Agreements Regulatory Affairs Branch Cancer Therapy Evaluation Program / Principal Investigator / Project Officer / physician / Officer / Extramural Principal Investigator / Contract Principal Investigator / authorized representative of Collaborator / contractor / Date Director / Division of Cancer Treatment and Diagnosis Address correspondence / Director / Grant Principal Investigator / Private / M.D. Date Director / Division of Cancer Treatment and Diagnosis Address correspondence / Chief / /
Product
Investigational Agents Sponsored / /
ProgrammingLanguage
C / /
ProvinceOrState
Indiana / District of Columbia / /
Technology
proposed combination protocols / research protocols / clinical research protocol / final approved protocol / treating cancer / /
August 2001 NCI - Collaborator Agent Clinical Trials Agreement (# 0000) Clinical Trials Agreement between and the Division of Cancer Treatment and Diagnosis, NCI